TrialClinical pharmacology and therapeutics2026

Clinical Validation of a QSP Model for ISB 2001, a Trispecific T Cell Engager to Support Optimal FIH Study Design in RRMM Patients.

Vinu Chandralayam Ayyappa Menon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.